November 12, 2020
Image of the new Vaccine Pic syringe virus
Pfizer announced on November 9th, 2020 that they had cleared the 3rd Phase of clinical trials regarding their new mRNA CV19 vaccine. They reported a 90% therapeutic success rate in protecting the majority of their 43,538 patient volunteers having already received the double dose preventive vaccine. There are only 4,600 volunteers still to receive the...
Read More